These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10180722)

  • 1. Impact of oropharyngeal deposition on inhaled dose.
    Dolovich M; Rhem R
    J Aerosol Med; 1998; 11 Suppl 1():S112-5. PubMed ID: 10180722
    [No Abstract]   [Full Text] [Related]  

  • 2. Mouth and oropharyngeal deposition of pharmaceutical aerosols.
    Clark AR; Newman SP; Dasovich N
    J Aerosol Med; 1998; 11 Suppl 1():S116-21. PubMed ID: 10180723
    [No Abstract]   [Full Text] [Related]  

  • 3. Metered dose inhaler aerosol deposition in a model of the human respiratory system and a comparison with clinical deposition studies.
    Velasquez DJ; Gabrio B
    J Aerosol Med; 1998; 11 Suppl 1():S23-8. PubMed ID: 10180729
    [No Abstract]   [Full Text] [Related]  

  • 4. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions.
    Bhavna ; Ahmad FJ; Mittal G; Jain GK; Malhotra G; Khar RK; Bhatnagar A
    Eur J Pharm Biopharm; 2009 Feb; 71(2):282-91. PubMed ID: 18984050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience.
    Salyer JW; DiBlasi RM; Crotwell DN; Cowan CA; Carter ER
    Respir Care; 2008 Mar; 53(3):338-45. PubMed ID: 18291050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heliox-driven albuterol nebulization for asthma exacerbations: an overview.
    Kim IK; Saville AL; Sikes KL; Corcoran TE
    Respir Care; 2006 Jun; 51(6):613-8. PubMed ID: 16723038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics of pressurized metered dose inhalers in vitro.
    Byron PR
    J Aerosol Med; 1997; 10 Suppl 1():S3-6. PubMed ID: 10165120
    [No Abstract]   [Full Text] [Related]  

  • 9. Albuterol aerosol delivered via metered-dose inhaler to intubated pediatric models of 3 ages, with 4 spacer designs.
    Mandhane P; Zuberbuhler P; Lange CF; Finlay WH
    Respir Care; 2003 Oct; 48(10):948-55. PubMed ID: 14525631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective bronchodilator resuscitation of children in the emergency room: device or interface?
    Ari A; Fink JB
    Respir Care; 2011 Jun; 56(6):882-5. PubMed ID: 21679497
    [No Abstract]   [Full Text] [Related]  

  • 11. Miniature inhalation therapy platform using surface acoustic wave microfluidic atomization.
    Qi A; Friend JR; Yeo LY; Morton DA; McIntosh MP; Spiccia L
    Lab Chip; 2009 Aug; 9(15):2184-93. PubMed ID: 19606295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro comparison of 4 large-volume nebulizers in 8 hours of continuous nebulization.
    Berlinski A; Willis JR; Leisenring T
    Respir Care; 2010 Dec; 55(12):1671-9. PubMed ID: 21122175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system.
    Perry SA; Kesser KC; Geller DE; Selhorst DM; Rendle JK; Hertzog JH
    Pediatr Crit Care Med; 2013 Jun; 14(5):e250-6. PubMed ID: 23628834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation.
    Di Paolo ER; Pannatier A; Cotting J
    Pediatr Crit Care Med; 2005 Jul; 6(4):462-9. PubMed ID: 15982436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric.
    Rau JL; Ari A; Restrepo RD
    Respir Care; 2004 Feb; 49(2):174-9. PubMed ID: 14744267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A system for the production and delivery of monodisperse salbutamol aerosols to the lungs.
    Biddiscombe MF; Usmani OS; Barnes PJ
    Int J Pharm; 2003 Mar; 254(2):243-53. PubMed ID: 12623200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
    Dhumal RS; Biradar SV; Paradkar AR; York P
    Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro characterisation of the nebulised dose during non-invasive ventilation.
    Abdelrahim ME; Plant P; Chrystyn H
    J Pharm Pharmacol; 2010 Aug; 62(8):966-72. PubMed ID: 20663030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful effects of aerosolized bronchodilator therapy in bronchiolitis.
    Bharti S; Bharti B; Goraya JS; Poddar B; Parmar VR
    Indian Pediatr; 1999 Oct; 36(10):1052-3. PubMed ID: 10745319
    [No Abstract]   [Full Text] [Related]  

  • 20. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.